EUDA Unveils Comprehensive Stem Cell Therapy Platform with Shenzhen Clinic Debut
Published: 24 Dec 2025
Author: Precedence Research
EUDA Health Holdings Ltd. Is a Singapore based biotech company has unveiled a complete stem cell therapy platform and opened its first specialized longevity clinics in Shenzhen, China, marking a significant advancement in its longevity-focused strategy. This action demonstrates the business's dedication to developing regenerative medicine and customized health solutions.
EUDA's new steam cell platform, which is housed in an upgraded Shenzhen facility that was previously run by Shenzhen Inno Immune Co., is essential to this expansion. These days, the facility serves as a production and innovation center for treatments such as immune cell therapies and induced pluripotent stem cells. The upgrade also includes cutting-edge technologies from Japanese partners and proprietary iPSC technology from Singapore-based GO [PSB Organoids which EUDA intends to purchase. Research on topics like skin rejuvenation, immune health, and anti-aging treatments is what the facility seeks to support.
In partnership with KB International Ltd, EUDA opened its first longevity clinic in Shenzhen in tandem with the manufacturing expansion. The clinic blends Eastern, Western, and functional medicine with cellular therapies and AI-driven health management. Its services are intended to assist patients in developing long-term health plans, enhancing immunity, and delaying biological aging. Additionally, EUDA has collaborated with medical facilities and research centers in Singapore, Japan, and the U.S., which encourages these efforts.
The dual launch, according to CEO Alfred Lim, is a significant milestone for EUDA, highlighting how the company is positioned as a leader in Asia, developing the longevity market by combining a therapy platform with a dedicated clinic. The plan expands the company's capacity in the field of regenerative health and corresponds with the increasing need for preventive healthcare in China, Singapore, and Malaysia's aging populations.
This announcement coincides with EUDA's recent strategies and initiatives, such as growing its digital health offerings by incorporating a utility token into its ecosystem and raising money through security purchase agreements. EUDA is well-positioned to offer science-driven longevity solutions with the Shenzhen clinic and stem cell platform supporting its goal of redefining wellness and aging in the area.